References

The value of biomarkers in major cardiovascular surgery necessitating cardiopulmonary bypass

10.31083/j.rcm2510355 · 2024 · External reference

ESC Joint working groups on cardiovascular surgery and the cellular biology of the heart position paper: perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery

10.1093/eurheartj/ehx383 · 2017 · External reference

The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia/reperfusion damage

10.1093/cvr/cvp110 · 2009 · External reference

Cell biology of ischemia/reperfusion injury

10.1016/b978-0-12-394309-5.00006-7 · 2012 · External reference

Myocardial ischemia reperfusion injury: from basic science to clinical bedside

10.1177/1089253211436350 · 2012 · External reference

Custodiol for myocardial protection and preservation: a systematic review

10.3978/j.issn.2225-319x.2013.11.10 · 2013 · External reference

History and use of del nido cardioplegia solution at Boston children’s hospital

10.1051/ject/201244098 · 2012 · External reference

Genomics and multiomics in the age of precision medicine

10.1038/s41390-025-04021-0 · 2025 · External reference

Systems biology in cardiovascular disease: a multiomics approach

10.1038/s41569-020-00477-1 · 2021 · External reference

Network pharmacology approaches to myocardial infarction reperfusion injury: exploring mechanisms, pathophysiology, and novel therapies

10.3390/biomedicines13071532 · 2025 · External reference

Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning

10.1161/circresaha.116.305348 · 2017 · External reference

Redox signalling and cardioprotection: translatability and mechanism

10.1111/bph.12975 · 2015 · External reference

Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation

10.1007/s00395-006-0584-5 · 2006 · External reference

Myocardial no-reflow in humans

10.1016/j.jacc.2009.03.054 · 2009 · External reference

Considerations on the management of acute postoperative ischaemia after cardiac surgery: a scientific statement from the American Heart Association

10.1161/cir.0000000000001154 · 2023 · External reference

Myocardial stunning: mechanisms, molecular insights, and gaps in knowledge

10.1042/bsr20253410 · 2025 · External reference

Atrial fibrillation occurring during acute hospitalization: a scientific statement from the American Heart Association

10.1161/cir.0000000000001133 · 2023 · External reference

Long-term continuous monitoring of new-onset atrial fibrillation after coronary artery bypass grafting

10.1001/jama.2025.14891 · 2025 · External reference

Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy

10.1016/j.amjcard.2010.03.032 · 2010 · External reference

Cyclosporine protects the heart during aortic valve surgery

10.1097/aln.0000000000000331 · 2014 · External reference

Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent

10.1111/j.1476-5381.2011.01700.x · 2012 · External reference

The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial

10.1136/heartjnl-2013-304845 · 2014 · External reference

The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin

10.1681/asn.2012121216 · 2013 · External reference

Role of cardiolipin in mitochondrial function and dynamics in health and disease: molecular and pharmacological aspects

10.3390/cells8070728 · 2019 · External reference

The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats

10.1038/s42003-020-1101-3 · 2020 · External reference

Phase 2a clinical trial of mitochondrial protection (elamipretide) during stent revascularization in patients with atherosclerotic renal artery stenosis

10.1161/circinterventions.117.005487 · 2017 · External reference

Novel mitochondria-targeting peptide in heart failure treatment: a randomized, placebo-controlled trial of elamipretide

10.1161/circheartfailure.117.004389 · 2017 · External reference

Elamipretide improves mitochondrial function in the failing human heart

10.1016/j.jacbts.2018.12.005 · 2019 · External reference

Mitochondrion-targeted carboxymethyl chitosan hybrid nanoparticles loaded with coenzyme Q10 protect cardiac grafts against cold ischaemia-reperfusion injury in heart transplantation

10.1186/s12967-023-04763-7 · 2023 · External reference

Mitochondrial ROS in myocardial ischemia reperfusion and remodeling

10.1016/j.bbadis.2020.165768 · 2020 · External reference

The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model

10.1016/j.healun.2015.05.007 · 2015 · External reference

The mitochondria-targeted antioxidant MitoQ ameliorates myocardial ischemia-reperfusion injury by enhancing PINK1/parkin-mediated mitophagy in type 2 diabetic rats

10.1007/s12192-022-01273-1 · 2022 · External reference

Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury

10.1096/fj.05-3718com · 2005 · External reference

Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue

10.1016/j.jtcvs.2004.03.034 · 2005 · External reference

The role of oral coenzyme Q10 in patients undergoing coronary artery bypass graft surgery

10.1053/j.jvca.2008.03.007 · 2008 · External reference

Ubiquinol supplementation in elderly patients undergoing aortic valve replacement: biochemical and clinical aspects

10.18632/aging.103742 · 2020 · External reference

Prophylactic treatment with coenzyme Q10 in patients undergoing cardiac surgery: could an antioxidant reduce complications? A systematic review and meta-analysis

10.1093/icvts/ivu334 · 2015 · External reference

No-reflow phenomenon: a contemporary review

10.3390/jcm11082233 · 2022 · External reference

Postoperative microcirculatory perfusion and endothelial glycocalyx shedding following cardiac surgery with cardiopulmonary bypass

10.1111/anae.14577 · 2019 · External reference

Microcirculatory perfusion disturbances following cardiopulmonary bypass: a systematic review

10.1186/s13054-020-02948-w · 2020 · External reference

Microcirculatory perfusion is preserved during off-pump but not on-pump cardiac surgery

10.1053/j.jvca.2013.05.026 · 2014 · External reference

The crucial triad: endothelial glycocalyx, oxidative stress, and inflammation in cardiac surgery: exploring the molecular connections

10.3390/ijms252010891 · 2024 · External reference

Correlation between acute degradation of the endothelial glycocalyx and microcirculation dysfunction during cardiopulmonary bypass in cardiac surgery

10.1016/j.mvr.2019.02.004 · 2019 · External reference

Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo

10.2337/diabetes.55.02.06.db05-1103 · 2006 · External reference

Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery

10.1038/nm.2022 · 2009 · External reference

Capillary pericytes regulate cerebral blood flow in health and disease

10.1038/nature13165 · 2014 · External reference

Capillary pericytes mediate coronary no-reflow after myocardial ischaemia

10.7554/elife.29280 · 2017 · External reference

Prolonged cardiopulmonary bypass time-induced endothelial dysfunction via glypican-1 shedding, inflammation, and matrix metalloproteinase 9 in patients undergoing cardiac surgery

10.3390/biomedicines13010033 · 2024 · External reference

Doxycycline can reduce glycocalyx shedding by inhibiting matrix metalloproteinases in patients undergoing cardiopulmonary bypass: a randomised controlled trial

10.1016/j.mvr.2022.104381 · 2022 · External reference

Effect of dexmedetomidine on endothelial glycocalyx in patients undergoing cardiac surgery with cardiopulmonary bypass

10.1053/j.jvca.2025.09.232 · 2026 · External reference

Microvascular dysfunction following cardiopulmonary bypass plays a central role in postoperative organ dysfunction

10.3389/fmed.2023.1110532 · 2023 · External reference

Total complement inhibition: an effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass

10.1161/01.cir.100.13.1438 · 1999 · External reference

Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass

10.1161/01.cir.0000138315.99788.eb · 2004 · External reference

Elevated circulating levels of neutrophil extracellular traps after cardiopulmonary bypass surgery as risk factors of postoperative atrial fibrillation and mortality

10.21037/jtd-24-295 · 2024 · External reference

Targeting of cell-free DNA by DNase I diminishes endothelial dysfunction and inflammation in a rat model of cardiopulmonary bypass

10.1038/s41598-019-55863-8 · 2019 · External reference

The low-dose colchicine in patients after non-CABG cardiac surgery: a randomized controlled trial

10.1186/s13054-023-04341-9 · 2023 · External reference

Colchicine reduces postoperative atrial fibrillation: results of the colchicine for the prevention of the postpericardiotomy syndrome (COPPS) atrial fibrillation substudy

10.1161/circulationaha.111.026153 · 2011 · External reference

Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial

10.1001/jama.2014.11026 · 2014 · External reference

Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials

10.1093/europace/euad169 · 2023 · External reference

Colchicine in patients with coronary disease who underwent coronary artery bypass surgery: a meta-analysis of randomized controlled trials

10.1016/j.amjcard.2024.09.003 · 2024 · External reference

Effects of N-acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery

10.1007/s00380-005-0873-1 · 2006 · External reference

Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass

10.1016/j.avsg.2008.12.005 · 2009 · External reference

N-acetylcysteine use among patients undergoing cardiac surgery: a systematic review and meta-analysis of randomized trials

10.1371/journal.pone.0213862 · 2019 · External reference

Efficacy of N-acetylcysteine in preventing acute kidney injury and major adverse cardiac events after cardiac surgery: a meta-analysis and trial sequential analysis

10.3389/fmed.2022.795839 · 2022 · External reference

N-acetylcysteine to reduce mortality for patients requiring cardiac catheterization or cardiac surgery: a systematic review and meta-analysis

10.1097/fjc.0000000000001551 · 2024 · External reference

Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery

10.1016/j.athoracsur.2007.01.003 · 2007 · External reference

The efficacy and safety of prophylactic corticosteroids for the prevention of adverse outcomes in patients undergoing heart surgery using cardiopulmonary bypass: a systematic review and meta-analysis of randomized controlled trials

10.1093/ejcts/ezz325 · 2020 · External reference

Corticosteroids in patients undergoing cardiac surgery: a meta-analysis of 12,559 patients

10.1177/02676591221106324 · 2023 · External reference

Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial

10.1016/s0140-6736(15)00273-1 · 2015 · External reference

The effects of corticosteroids on survival in pediatric and nonelderly adult patients undergoing cardiac surgery: a meta-analysis of randomized studies

10.1053/j.jvca.2024.07.001 · 2024 · External reference

Cardioprotection: chances and challenges of its translation to the clinic

10.1016/s0140-6736(12)60916-7 · 2013 · External reference

Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning

10.1124/pharmrev.121.000348 · 2023 · External reference

Multitarget strategies to reduce myocardial ischaemia/reperfusion injury

10.1016/j.jacc.2018.09.086 · 2019 · External reference

From “omics” to multi-omics technologies: the discovery of novel causal mediators

10.1007/s11883-022-01078-8 · 2023 · External reference

Multiomics network medicine approaches to precision medicine and therapeutics in cardiovascular diseases

10.1161/atvbaha.122.318731 · 2023 · External reference

Integrative omics for health and disease

10.1038/nrg.2018.4 · 2018 · External reference

Network medicine: a network-based approach to human disease

10.1038/nrg2918 · 2011 · External reference

Multi-omics profiling for health

10.1016/j.mcpro.2023.100561 · 2023 · External reference

Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery

10.1161/circulationaha.105.001032 · 2006 · External reference

Genome-wide association study of myocardial infarction, atrial fibrillation, acute stroke, acute kidney injury and delirium after cardiac surgery—a sub-analysis of the RIPHeart-study

10.1186/s12872-019-1002-x · 2019 · External reference

Gene polymorphisms and cytokine plasma levels as predictive factors of complications after cardiopulmonary bypass

10.1016/j.jtcvs.2011.12.022 · 2012 · External reference

Longitudinal profiling in patients undergoing cardiac surgery reveals postoperative changes in DNA methylation

10.1186/s13148-022-01414-4 · 2022 · External reference

Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4

10.1093/cvr/cvq082 · 2010 · External reference

Plasma levels of microRNA-499 provide an early indication of perioperative myocardial infarction in coronary artery bypass graft patients

10.1371/journal.pone.0104618 · 2014 · External reference

Using next-generation RNA sequencing to examine ischemic changes induced by cold blood cardioplegia on the human left ventricular myocardium transcriptome

10.1097/aln.0000000000000582 · 2015 · External reference

Preoperative soluble VCAM-1 contributes to predict late mortality after coronary artery surgery

10.1002/clc.23443 · 2020 · External reference

Prognostic role of serum high mobility group box 1 concentration in cardiac surgery

10.1038/s41598-020-63051-2 · 2020 · External reference

The association between novel biomarkers and 1-year readmission or mortality after cardiac surgery

10.1016/j.athoracsur.2018.04.084 · 2018 · External reference

Soluble urokinase plasminogen activator receptor and survival in elective cardiac surgery

10.1111/eci.13953 · 2023 · External reference

Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS

10.1038/nature13909 · 2014 · External reference

A longitudinal serum NMR-based metabolomics dataset of ischemia-reperfusion injury in adult cardiac surgery

10.1038/s41597-020-0545-0 · 2020 · External reference

Metabolomic profiling reveals distinct patterns of myocardial substrate use in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia/reperfusion

10.1161/circulationaha.108.816116 · 2009 · External reference

New biomarkers from multiomics approaches: improving risk prediction of atrial fibrillation

10.1093/cvr/cvab073 · 2021 · External reference

Artificial intelligence in precision cardiovascular medicine

10.1016/j.jacc.2017.03.571 · 2017 · External reference

High-performance medicine: the convergence of human and artificial intelligence

10.1038/s41591-018-0300-7 · 2019 · External reference

Machine learning improves mortality risk prediction after cardiac surgery: systematic review and meta-analysis

10.1016/j.jtcvs.2020.07.105 · 2022 · External reference

Transforming cardiovascular care with artificial intelligence: from discovery to practice: JACC state-of-the-art review

10.1016/j.jacc.2024.05.003 · 2024 · External reference

Use of artificial intelligence in improving outcomes in heart disease: a scientific statement from the American Heart Association

10.1161/cir.0000000000001201 · 2024 · External reference

AI-driven drug-target interaction prediction: current progress, challenges, and future roadmap for precision medicine

10.1007/s10822-026-00798-2 · 2026 · External reference

Personalized anesthesia and precision medicine: a comprehensive review of genetic factors, artificial intelligence, and patient-specific factors

10.3389/fmed.2024.1365524 · 2024 · External reference

Integrated multi-omics for rapid rare disease diagnosis on a national scale

10.1038/s41591-023-02401-9 · 2023 · External reference

Challenges and opportunities in multi-omics data acquisition and analysis: toward integrative solutions

10.3390/biom16020271 · 2026 · External reference

Explainability for artificial intelligence in healthcare: a multidisciplinary perspective

10.1186/s12911-020-01332-6 · 2020 · External reference

The role of explainability in creating trustworthy artificial intelligence for health care: a comprehensive survey of the terminology, design choices, and evaluation strategies

10.1016/j.jbi.2020.103655 · 2021 · External reference

Ensuring fairness in machine learning to advance health equity

10.7326/m18-1990 · 2018 · External reference

Sociodemographic bias in clinical machine learning models: a scoping review of algorithmic bias instances and mechanisms

10.1016/j.jclinepi.2024.111606 · 2025 · External reference

Effects of elamipretide on left ventricular function in patients with heart failure with reduced ejection fraction: the PROGRESS-HF phase 2 trial

10.1016/j.cardfail.2020.02.001 · 2020 · External reference